Cancer
Malignant Colon Neoplasm
CI-CAN-00007995Explore in graph →
Top-level225 active trials5 approved drugs17 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00007995Explore in graph →
Clinical trials
1,197 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (139)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01239095 | Oral Green Tea Extract and Milk Thistle Extract to Colorectal Cancer Patients Undergoing Resection | terminated | Phase 1 | 23 | Richard WhelanOTHER | 1 | Feb 22, 2023 | clinicaltrials |
| NCT03750461 | Stoma Closure and Reinforcement Trial(SCAR) | completed | N/A | 20 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Feb 22, 2023 | clinicaltrials |
| NCT04548531 |
| Engaging Patients in Colon Cancer Screening Decisions During COVID-19 |
| completed |
| N/A |
| 800 |
| Massachusetts General HospitalOTHER |
| 1 |
| Feb 22, 2023 |
| clinicaltrials |
| NCT02890758 | Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803 | completed | Phase 1 | 14 | Brenda Cooper, MDOTHER | 1 | Feb 21, 2023 | clinicaltrials |
| NCT03871959 | Pembrolizumab In Combination With Debio 1143 In Pancreatic and Colorectal Advanced/Metastatic Adenocarcinoma(CATRIPCA) | completed | Phase 1 | 54 | Centre Leon BerardOTHER | 1 | Feb 17, 2023 | clinicaltrials |
| NCT05732493 | Short-course Radiotherapy Combined With Chemotherapy and Pd-1 Inhibitor for Locally Advanced Colon Cancer(TORCH-C)(TORCH-C) | unknown | Phase 2 | 120 | Fudan UniversityOTHER | 0 | Feb 17, 2023 | clinicaltrials |
| NCT03462706 | Quad Resection (Hot Snare vs Cold Snare vs Hot EMR vs Cold EMR) | completed | N/A | 238 | Indiana UniversityOTHER | 1 | Feb 15, 2023 | clinicaltrials |
| NCT03871790 | Peptide-based Immunization for Colon- and and Pancreas-carcinoma(PICOP-GLOBAL) | completed | — | 50 | CENTOGENE GmbH RostockINDUSTRY | 1 | Feb 10, 2023 | clinicaltrials |
| NCT05638048 | Effect of Precise Grip Strength Training on PICC Catheter-Related Thrombosis in Cancer Patients | completed | N/A | 270 | Junyan ZhaoOTHER | 1 | Feb 3, 2023 | clinicaltrials |
| NCT02728804 | S1417CD Financial Impact Assessment Tool in Patients With Metastatic Colorectal Cancer | completed | — | 380 | SWOG Cancer Research NetworkNETWORK | 1 | Jan 26, 2023 | clinicaltrials |
| NCT02324374 | Endocytoscopy and Colorectal Neoplasia | completed | N/A | 50 | University of PennsylvaniaOTHER | 1 | Jan 25, 2023 | clinicaltrials |
| NCT04476082 | Nutrition in Gastrointestinal Tumors(NutriGIT) | completed | — | 66 | University Medicine GreifswaldOTHER | 1 | Jan 25, 2023 | clinicaltrials |
| NCT05696002 | Advanced Pelvic Surgical Oncology Database - Prospective Observational Study | recruiting | — | 300 | Glasgow Royal InfirmaryOTHER | 1 | Jan 25, 2023 | clinicaltrials |
| NCT04044430 | Encorafenib, Binimetinib, and Nivolumab in Treating Microsatellite Stable BRAF V600E Metastatic Colorectal Cancer | terminated | Phase 1 | 2 | University of California, San FranciscoOTHER | 1 | Jan 9, 2023 | clinicaltrials |
| NCT05675904 | Textbook Outcome in Colon Carcinoma | completed | — | 564 | Hospital General Universitario de AlicanteOTHER | 1 | Jan 9, 2023 | clinicaltrials |
| NCT03407716 | Ginseng in Decreasing Cancer-Related Fatigue After Treatment in Cancer Survivors | completed | Early Phase 1 | 2 | Mayo ClinicOTHER | 1 | Jan 5, 2023 | clinicaltrials |
| NCT01882660 | Pre-operative Decitabine in Colon Cancer: a Proof of Principle Study(DECO) | terminated | N/A | 10 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Dec 19, 2022 | clinicaltrials |
| NCT03883802 | Foxy-5 as Neo-Adjuvant Therapy in Subjects With Wnt-5a Low Colon Cancer(NeoFox) | unknown | Phase 2 | 100 | WntResearch ABINDUSTRY | 1 | Dec 9, 2022 | clinicaltrials |
| NCT02810652 | Perioperative Geriatrics Intervention for Older Cancer Patients Undergoing Surgical Resection | completed | N/A | 160 | Massachusetts General HospitalOTHER | 1 | Nov 22, 2022 | clinicaltrials |
| NCT04871399 | Complete Mesocolic Excision in Comparison With Conventional Surgery for the Right Colon Cancer(CoME-In) | recruiting | N/A | 416 | University of Turin, ItalyOTHER | 1 | Nov 14, 2022 | clinicaltrials |
| NCT05178576 | A Single Arm Phase II Study to Evaluate Treatment With Gevokizumab in Patients With Stage II/III Colon Cancer Who Are ctDNA-positive After Curative Surgery and Adjuvant Chemotherapy | withdrawn | Phase 2 | 0 | NSABP Foundation IncNETWORK | 1 | Nov 4, 2022 | clinicaltrials |
| NCT00986661 | A Study to Assess PV-10 Chemoablation of Cancer of the Liver | unknown | Phase 1 | 78 | Provectus Biopharmaceuticals, Inc.INDUSTRY | 1 | Nov 2, 2022 | clinicaltrials |
| NCT04827459 | Sleep Coach: A Mobile App to Address Insomnia Symptoms Among Cancer Survivors | completed | N/A | 30 | University of Michigan Rogel Cancer CenterOTHER | 1 | Nov 2, 2022 | clinicaltrials |
| NCT05266300 | Implementation and Quality Assurance of DPYD-genotyping in Patients Treated With Fluoropyrimidines. | completed | — | 722 | University of Southern DenmarkOTHER | 1 | Nov 1, 2022 | clinicaltrials |
| NCT05446558 | Long-term Results in Intracorporeal Versus Extracorporeal Anastomosis in Laparoscopic Right Colectomy | unknown | N/A | 140 | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauOTHER | 1 | Oct 31, 2022 | clinicaltrials |
| NCT05433402 | Repurposing the Antipsychotic Drug Chlorpromazine as Adjuvant Therapeutic Agent for Resected Stage III Colon Cancer | withdrawn | Phase 1 / Phase 2 | 0 | Sadat City UniversityOTHER | 1 | Oct 27, 2022 | clinicaltrials |
| NCT05536362 | Propofol With Clonidine and Ketamine Throughout Colon Cancer Surgery | completed | Phase 1 | 60 | EgymedicalpediaINDUSTRY | 1 | Oct 26, 2022 | clinicaltrials |
| NCT03693846 | Nivolumab and Ipilimumab in Mucinous Colorectal and Appendiceal Tumors | terminated | Phase 2 | 11 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Oct 20, 2022 | clinicaltrials |
| NCT04527861 | Oncologic Outcomes of Single-incision Versus Conventional Laparoscopic Surgery for Colorectal Cancer(CSILS) | recruiting | N/A | 710 | Ruijin HospitalOTHER | 1 | Oct 10, 2022 | clinicaltrials |
| NCT03827044 | Avelumab Plus 5-FU Based Chemotherapy as Adjuvant Treatment for Stage 3 MSI-High or POLE Mutant Colon Cancer(POLEM) | terminated | Phase 3 | 30 | Royal Marsden NHS Foundation TrustOTHER | 1 | Oct 7, 2022 | clinicaltrials |
| NCT03781778 | Pilot Trial of Resistant Starch in Stage I-III Colorectal Cancer Survivors | terminated | Phase 2 | 10 | Fred Hutchinson Cancer CenterOTHER | 1 | Oct 6, 2022 | clinicaltrials |
| NCT05529615 | Circulating Tumor DNA Guided Adjuvant Chemotherapy for Colon Cancer(CTAC) | recruiting | N/A | 2,684 | Peking University Cancer Hospital & InstituteOTHER | 1 | Sep 7, 2022 | clinicaltrials |
| NCT02363647 | Personalized Cancer Therapy for Patients With Metastatic Medullary Thyroid or Metastatic Colon Cancer | terminated | N/A | 10 | Icahn School of Medicine at Mount SinaiOTHER | 1 | Aug 31, 2022 | clinicaltrials |
| NCT05018325 | Assessing Effect of Withdrawal Time on Adenoma Detection Rate for Screening Colonoscopy | terminated | N/A | 32 | Washington University School of MedicineOTHER | 1 | Aug 31, 2022 | clinicaltrials |
| NCT04606992 | Combined Endoscopic and Laparoscopic Surgery (CELS) for Early Colon Cancer in High Risk Patients | completed | N/A | 25 | Zealand University HospitalOTHER | 1 | Aug 16, 2022 | clinicaltrials |
| NCT03524820 | Cetuximab Therapy for Third Line Rechallenge in Metastatic Colorectal Cancer | terminated | Phase 2 | 3 | Hadassah Medical OrganizationOTHER | 1 | Aug 4, 2022 | clinicaltrials |
| NCT03719573 | Geriatric Assessment and Intervention in Older Patients Undergoing Surgery for Colorectal Cancer(GEPOC) | completed | N/A | 67 | Herlev and Gentofte HospitalOTHER | 1 | Aug 3, 2022 | clinicaltrials |
| NCT02602327 | Tas-102 and Radioembolization With 90Y Resin Microspheres for Chemo-refractory Colorectal Liver Metastases | completed | Phase 1 | 21 | University of California, San FranciscoOTHER | 1 | Aug 1, 2022 | clinicaltrials |
| NCT03291951 | FOcus on Reducing Dose-limiting Toxicities in Colon Cancer With Resistance Exercise Study(FORCE) | completed | N/A | 183 | Kaiser PermanenteOTHER | 1 | Jul 28, 2022 | clinicaltrials |
| NCT04685551 | Improving Survivorship Among Minority Cancer Dyads | withdrawn | N/A | 0 | Charles Drew University of Medicine and ScienceOTHER | 1 | Jul 26, 2022 | clinicaltrials |
| NCT01896778 | Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With Cancer | completed | N/A | 9 | Roswell Park Cancer InstituteOTHER | 1 | Jul 25, 2022 | clinicaltrials |
| NCT04351009 | Sentinel Lymph Node Mapping and Analysis in Colon Cancer Using Indocyanine Green Dye | completed | N/A | 48 | Asian Institute of Gastroenterology, IndiaOTHER | 1 | Jul 6, 2022 | clinicaltrials |
| NCT04628182 | The China Laparoscopic Right Hemicolectomy SNAPSHOT | unknown | — | 1,579 | Beijing Friendship HospitalOTHER | 1 | Jun 30, 2022 | clinicaltrials |
| NCT04630327 | Validation of the Russian and Kazakh Versions of the Beck Depression Inventory and Beck Anxiety Inventory | completed | — | 226 | Kazakh Medical University of Continuing EducationOTHER | 1 | Jun 21, 2022 | clinicaltrials |
| NCT05099211 | Neuromuscular Deconditioning and Reconditioning in Colon Cancer Patients: an APA Muscle Rendorcement Program(REMUSCLON) | unknown | N/A | 60 | Centre Hospitalier Universitaire DijonOTHER | 1 | Jun 21, 2022 | clinicaltrials |
| NCT05424939 | Management of Obstructive Colon Tumors in Istanbul | unknown | — | 500 | Istanbul Medipol University HospitalOTHER | 1 | Jun 21, 2022 | clinicaltrials |
| NCT05426135 | Artificial Intelligence System for Assessment of Tumor Risk and Diagnosis and Treatment | recruiting | — | 3,000 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 1 | Jun 21, 2022 | clinicaltrials |
| NCT05422547 | Role of Immunoscore® in Stage II-III Colorectal Cancer | unknown | — | 100 | D'Or Institute for Research and EducationOTHER | 1 | Jun 16, 2022 | clinicaltrials |
| NCT02959541 | PK/PD Investigation of Calciumfolinat in Blood, Tumor and Adjacent Mucosa in Patient With Colon Cancer | unknown | N/A | 48 | Vastra Gotaland RegionOTHER_GOV | 1 | Jun 13, 2022 | clinicaltrials |
Data updated 23 days agoSource updated Feb 22, 2023source: clinicaltrials